[SCHEDULE 13G] Omada Health, Inc. SEC Filing

Rhea-AI Filing Summary

Revelation-affiliated entities and two managing members reported beneficial ownership positions in Omada Health's common stock. Michael Boggs and Scott Halsted each report beneficial ownership of 5,208,034 shares, representing 9.1% of the outstanding stock, while Revelation Healthcare Fund IV reports 3,095,306 shares (5.4%). Several Revelation entities report smaller positions (0.9%–2.3%).

The statement shows these reporting persons have sole voting and sole dispositive power over the shares disclosed and uses a public share count of 56,929,340 shares to calculate percentages. The filing is a disclosure of ownership levels by related funds and their managers; it does not announce transactions, changes in control, or other operational developments within the company.

Positive

• Clear disclosure of beneficial ownership by Revelation-affiliated funds and managers, including exact share counts and percentages
• Material insider stakes reported: Michael Boggs and Scott Halsted each beneficially own 5,208,034 shares (9.1%), and Revelation Healthcare Fund IV holds 3,095,306 shares (5.4%)
• Sole voting and dispositive power is reported for the disclosed shares, clarifying who controls voting rights for these positions

Negative

• None.

Insights

Financial Analyst

TL;DR: Significant insider and affiliated-fund ownership disclosed: two managers each hold 9.1%, and Fund IV holds 5.4%.

The Schedule 13G reports concentrated ownership among Revelation-affiliated funds and their managers, with Michael Boggs and Scott Halsted each beneficially owning 5,208,034 shares (9.1%). Percentages are calculated on a stated outstanding share base of 56,929,340 shares. The holders report sole voting and dispositive power over these shares, which is important for assessing shareholder alignment and potential voting outcomes on corporate matters. This disclosure is informational and does not, by itself, indicate a change in ownership intent or a control transaction.

Corporate Governance Expert

TL;DR: Material insider stakes exceed 5%, giving these managers meaningful influence over governance decisions.

The filing shows that related funds and their managing members hold material positions: Fund IV 5.4% and two managing members 9.1% each. Because the reported holdings are held with sole voting authority, these reporting persons are positioned to materially influence shareholder votes and governance outcomes. The disclosure increases transparency about beneficial ownership structure but does not include any proposed governance actions or changes.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Omada Health, Inc.

(Name of Issuer)

Common stock, $0.001 par value per share

(Title of Class of Securities)

68170A108

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

Revelation Alpine, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 492,886.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 492,886.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

492,886.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.9 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

Revelation Alpine, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 816,993.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 816,993.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

816,993.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.4 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

Revelation Alpine GP, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,309,879.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,309,879.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,309,879.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

2.3 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

REVELATION HEALTHCARE FUND II, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 802,849.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 802,849.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

802,849.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.4 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

Revelation Healthcare Fund II GP, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 802,849.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 802,849.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

802,849.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.4 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

Revelation Healthcare Fund II GP, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 802,849.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 802,849.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

802,849.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.4 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

REVELATION HEALTHCARE FUND IV, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,095,306.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,095,306.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,095,306.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.4 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

Revelation Healthcare Fund IV GP, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,095,306.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,095,306.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,095,306.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.4 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

Revelation Healthcare Fund IV GP, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,095,306.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,095,306.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,095,306.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.4 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

Michael Boggs

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 5,208,034.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 5,208,034.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

5,208,034.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.1 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

CUSIP No. 68170A108

1

Names of Reporting Persons

Scott Halsted

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 5,208,034.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 5,208,034.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

5,208,034.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.1 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Omada Health, Inc.
(b)	Address of issuer's principal executive offices: 500 Sansome Street, Suite 200 San Francisco, CA, 94111
Item 2.
(a)	Name of person filing: This Schedule 13G is being filed by (i) Revelation Alpine, LLC ("Alpine LLC"), (ii) Revelation Alpine, L.P. ("Alpine LP"), (iii) Revelation Alpine GP, LLC ("Alpine GP"), (iv) Revelation Healthcare Fund II, L.P. ("Fund II"), (v) Revelation Healthcare Fund II GP, L.P. ("Fund II GP"), (vi) Revelation Healthcare Fund II GP, LLC ("Fund II GP LLC"), (vii) Revelation Healthcare Fund IV, L.P. ("Fund IV"), (viii) Revelation Healthcare Fund IV GP, L.P. ("Fund IV GP"), (ix) Revelation Healthcare Fund IV GP, LLC ("Fund IV GP LLC"), (x) Michael Boggs and (xi) Scott Halsted. The foregoing are sometimes referred to collectively as the "Reporting Persons".
(b)	Address or principal business office or, if none, residence: The address of the principal business and principal office of each of the Reporting Persons is 300 Turney Street, 2nd Floor, Sausalito, CA 94965.
(c)	Citizenship: Each of Alpine LLC, Alpine LP, Alpine GP, Fund II, Fund II GP, Fund II GP LLC, Fund IV, Fund IV GP and Fund IV GP LLC is incorporated under the laws of Delaware. Messrs. Boggs and Halsted are citizens of the United States.
(d)	Title of class of securities: Common stock, $0.001 par value per share
(e)	CUSIP No.: 68170A108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Alpine LLC directly owns 492,886 shares of the Issuer's Common Stock, Alpine LP directly owns 816,993 shares of the Issuer's Common Stock, Fund II directly owns 802,849 shares of the Issuer's Common Stock and Fund IV directly owns 3,095,306 shares of the Issuer's Common Stock. Alpine GP, as the manager of Alpine LLC and general partner of Alpine LP, may be deemed to beneficially own the shares of Common Stock held by Alpine LLC and Alpine LP. Each of Fund II GP, as the general partner of Fund II, and Fund II GP LLC, as the general partner of Fund II GP, may be deemed to be beneficially own the shares of Common Stock held by Fund II. Each of Fund IV GP, as the general partner of Fund IV, and Fund IV GP LLC, as the general partner of Fund IV GP, may be deemed to beneficially own the shares of Common Stock held by Fund IV. Messrs. Boggs and Halsted are the managing members of Alpine GP, Fund II GP LLC and Fund IV GP LLC and in such capacity make investment and voting decisions on behalf of Alpine LLC, Alpine LP, Fund II and Fund IV.
(b)	Percent of class: Alpine LLC: 0.9% Alpine LP: 1.4% Alpine GP: 2.3% Fund II: 1.4% Fund II GP: 1.4% Fund II GP LLC: 1.4% Fund IV: 5.4% Fund IV GP: 5.4% Fund IV GP LLC: 5.4% Michael Boggs: 9.1% Scott Halsted: 9.1% The foregoing percentages were based upon 56,929,340 shares of the Common Stock outstanding as disclosed in the Issuer's Form 424(b)(4) prospectus filed on June 9, 2025, after giving effect to the underwriters' exercise in full of their option to purchase additional shares.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Alpine LLC: 492,886 shares of Common Stock Alpine LP: 816,993 shares of Common Stock Alpine GP: 1,309,879 shares of Common Stock Fund II: 802,849 shares of Common Stock Fund II GP: 802,849 shares of Common Stock Fund II GP LLC: 802,849 shares of Common Stock Fund IV: 3,095,306 shares of Common Stock Fund IV GP: 3,095,306 shares of Common Stock Fund IV GP LLC: 3,095,306 shares of Common Stock Michael Boggs: 5,208,034 shares of Common Stock Scott Halsted: 5,208,034 shares of Common Stock
	(ii) Shared power to vote or to direct the vote: N/A
	(iii) Sole power to dispose or to direct the disposition of: Alpine LLC: 492,886 shares of Common Stock Alpine LP: 816,993 shares of Common Stock Alpine GP: 1,309,879 shares of Common Stock Fund II: 802,849 shares of Common Stock Fund II GP: 802,849 shares of Common Stock Fund II GP LLC: 802,849 shares of Common Stock Fund IV: 3,095,306 shares of Common Stock Fund IV GP: 3,095,306 shares of Common Stock Fund IV GP LLC: 3,095,306 shares of Common Stock Michael Boggs: 5,208,034 shares of Common Stock Scott Halsted: 5,208,034 shares of Common Stock
	(iv) Shared power to dispose or to direct the disposition of: N/A
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Revelation Alpine, LLC

Signature:	/s/ Michael Boggs
Name/Title:	Michael Boggs, Managing Member of Manager
Date:	08/12/2025

Revelation Alpine, L.P.

Signature:	/s/ Michael Boggs
Name/Title:	Michael Boggs, Managing Member of General Partner
Date:	08/12/2025

Revelation Alpine GP, LLC

Signature:	/s/ Michael Boggs
Name/Title:	Michael Boggs, Managing Member
Date:	08/12/2025

REVELATION HEALTHCARE FUND II, L.P.

Signature:	/s/ Michael Boggs
Name/Title:	Michael Boggs, Managing Member of General Partner of General Partner
Date:	08/12/2025

Revelation Healthcare Fund II GP, L.P.

Signature:	/s/ Michael Boggs
Name/Title:	Michael Boggs, Managing Member of General Partner
Date:	08/12/2025

Revelation Healthcare Fund II GP, LLC

Signature:	/s/ Michael Boggs
Name/Title:	Michael Boggs, Managing Member
Date:	08/12/2025

REVELATION HEALTHCARE FUND IV, L.P.

Signature:	/s/ Michael Boggs
Name/Title:	Michael Boggs, Managing Member of General Partner of General Partner
Date:	08/12/2025

Revelation Healthcare Fund IV GP, L.P.

Signature:	/s/ Michael Boggs
Name/Title:	Michael Boggs, Managing Member of General Partner
Date:	08/12/2025

Revelation Healthcare Fund IV GP, LLC

Signature:	/s/ Michael Boggs
Name/Title:	Michael Boggs, Managing Member
Date:	08/12/2025

Michael Boggs

Signature:	/s/ Michael Boggs
Name/Title:	Michael Boggs
Date:	08/12/2025

Scott Halsted

Signature:	/s/ Scott Halsted
Name/Title:	Scott Halsted
Date:	08/12/2025

FAQ

Who filed the Schedule 13G for Omada Health (OMDA)?

The filing was made by Revelation-affiliated entities and individuals: Revelation Alpine, LLC; Revelation Alpine, L.P.; Revelation Alpine GP, LLC; Revelation Healthcare Fund II, L.P.; Revelation Healthcare Fund II GP entities; Revelation Healthcare Fund IV, L.P.; Revelation Healthcare Fund IV GP entities; Michael Boggs; and Scott Halsted.

How many shares does Michael Boggs beneficially own according to the filing?

5,208,034 shares, representing 9.1% of Omada Health's common stock as reported in the statement.

Does any reporting person own more than 5% of OMDA?

Yes. Michael Boggs and Scott Halsted each own 9.1%, and Revelation Healthcare Fund IV owns 5.4% of the outstanding common stock.

What share count was used to calculate the ownership percentages?

Percentages are based on an outstanding share count of 56,929,340 shares, as disclosed in the issuer's prospectus referenced in the filing.

Do the reporting persons have voting control over the shares they report?

Yes. The filing states that the reporting persons have sole voting power and sole dispositive power for the shares disclosed.

Did the Schedule 13G report any purchases, sales, or change in control?

No. The document discloses beneficial ownership levels but does not report transactions, sales, or any proposed change in control.